April 11, 2023

Registration Opens for Access Insights Conference 2023

Registration is now open to all pharma manufacturers for the Access Insights Conference 2023, co-hosted by IntegriChain and Blue Fin Group. The Access Insights Conference will be held November 6-8, 2023, at the JW Marriott Orlando Bonnet Creek. Designed for commercial, operational, and financial teams at pharma manufacturers, the conference will feature industry panels, exclusive ICyte Benchmark data, and strategic and tactical best practices for data-driven patient access and therapy commercialization.

January 20, 2023

IntegriChain Appoints Josh Halpern Chief Executive Officer

IntegriChain names Joshua Halpern, co-founder and current President and Chief Operating Officer, as new Chief Executive Officer effective February 1, 2023. Kevin Leininger, current CEO, will transition to the role of Executive Chairman and remain active in the business strategy.

October 25, 2022

IntegriChain Presents Annual Customer Awards to Cytokinetics, Sebela, Boehringer Ingelheim, and Alkermes

We presented our annual customer awards to innovators and visionaries in market access and commercialization. The company awards included Market Access Visionary Award to Cytokinetics, Lighthouse Award for Innovation to Sebela Pharmaceuticals, and the Patient and Channel Data Trailblazer to Boehringer Ingelheim. An individual award, the ICyte Power User Award, was presented to Jim Delaney, Senior Director, National Channel Accounts at Alkermes.

October 3, 2022

IntegriChain Medicaid  Pricing Experts to Speak at MDRP

Two Contracts & Pricing experts will present at Informa’s upcoming Medicaid Drug Rebate Program (MDRP) conference on digital pharmacy models and the value-based purchasing final rule. IntegriChain is a sponsor of the conference, which runs in person October 12 - 14, 2022.

July 6, 2022

Blue Fin Group Presents Market Research Study on Current and Future Payer Management in Oncology

Blue Fin Group today announced a new market research study video assessing current and future payer management in oncology including influences on payer decision-making to prefer drugs in oncology, top barriers and influencers to manage oncolytics, and oncology management expectations in the next three years, including increasing contracting for preference and value-based contracting.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article